Pirfenidone
- Product NDC
- 62332-480
- 11-digit product format
- 623320480
- Labeler code
- 62332
- Product ID
- 62332-480_9f41a23e-cc34-4b25-871d-deeef997fe8d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pirfenidone
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Alembic Pharmaceuticals Inc.
- Application
- ANDA212708
- Marketing category
- ANDA
- Marketing start
- 2022-06-10
- Substance
- PIRFENIDONE
- Active strength
- 801 mg/1
- Pharmacologic classes
- Pyridone [EPC], Pyridones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pirfenidone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PIRFENIDONE | 801 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | D7NLD2JX7U |
| Rxcui | 1868014, 1868018 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62332-480-71 | Pirfenidone | 500 in 1 BOTTLE | TABLET, COATED | 500 | | 9 |
| 62332-480-90 | Pirfenidone | 90 in 1 BOTTLE | TABLET, COATED | 90 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62332-480 | PIRFENIDONE TABLET, COATED [ALEMBIC PHARMACEUTICALS INC.] | 9 | Current NDC, Legacy NDC, 2 package rows | 20231208_9214862e-9ef7-4370-856a-f5697978270a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62332-480-71 | 62332048071 | 500 TABLET, COATED in 1 BOTTLE (62332-480-71) | 2022-06-10 | 0000-00-00 | No | No | Current |
| 62332-480-90 | 62332048090 | 90 TABLET, COATED in 1 BOTTLE (62332-480-90) | 2022-06-10 | 0000-00-00 | No | No | Current |